Increased Serum Adipocyte Fatty Acid-Binding Protein Levels Are Associated with Decreased Sensitivity to Thyroid Hormones in the Euthyroid Population
- 1 December 2020
- journal article
- research article
- Published by Mary Ann Liebert Inc in Thyroid®
- Vol. 30 (12), 1718-1723
- https://doi.org/10.1089/thy.2020.0011
Abstract
Background: Serum adipocyte fatty acid-binding protein (A-FABP) and thyroid hormones are closely associated with metabolic disorders; however, their relationship remains unknown. We aimed to investigate the associations of serum A-FABP levels with single and composite indices of the thyroid system. Methods: The study included 1057 community-based euthyroid participants (age range: 27-81 years) in Shanghai, among whom 601 were women. Serum free triiodothyronine (FT3), free thyroxine (FT4) and thyroid stimulating hormone (TSH) were measured by electrochemical luminescence immunoassay. The thyroid feedback quantile-based index (TFQI), thyroid stimulating hormone index (TSHI) and thyrotroph thyroxine resistance index (TT4RI) were calculated to evaluate central sensitivity to thyroid hormones. Peripheral sensitivity to thyroid hormones was evaluated by the FT3 to FT4 ratio (FT3/FT4). Enzyme linked immunosorbent assay was used to measure serum A-FABP levels. Results: Serum A-FABP levels were 6.41 (95% confidence interval: 6.10-6.74) ng/ml among all subjects. Multiple cardiovascular metabolic risk factors were adjusted in the multivariate linear regression analysis and the multinomial logistic regression analysis (non-ordinal). In both sexes, serum A-FABP levels were positively associated with FT4 (men: standardized β = 0.150, P = 0.001; women: standardized β = 0.218, P < 0.001), TFQI (men: standardized β = 0.119, P = 0.009; women: standardized β = 0.165, P < 0.001) and TSHI (men: standardized β = 0.108, P = 0.017; women: standardized β = 0.114, P = 0.005), while they were negatively associated with FT3/FT4 (men: standardized β = -0.122, P = 0.008; women: standardized β = -0.129, P = 0.001). Serum A-FABP levels were not associated with FT3, TSH or TT4RI. Compared with the first quartile group of TFQI, for every 10 ng/ml increase in A-FABP, the odds ratio for the third quartile group of TFQI was 2.213 in women (P = 0.035); the odds ratios for the fourth quartile group of TFQI were 2.614 in men (P = 0.022) and 3.425 in women (P = 0.002). Conclusions: In an euthyroid population, increased serum A-FABP levels were associated with decreased sensitivity to thyroid hormones, suggesting that A-FABP may mediate the “cross-talk” between adipose tissue and the thyroid system.Keywords
This publication has 38 references indexed in Scilit:
- Adiponectin and adipocyte fatty acid binding protein in the pathogenesis of cardiovascular diseaseAmerican Journal of Physiology-Heart and Circulatory Physiology, 2012
- Impaired Metabolic Effects of a Thyroid Hormone Receptor Beta-Selective Agonist in a Mouse Model of Diet-Induced ObesityThyroid®, 2010
- Reducing endoplasmic reticulum stress through a macrophage lipid chaperone alleviates atherosclerosisNature Medicine, 2009
- The use of thyroid function tests in the diagnosis of hypopituitarism: definition and evaluation of the TSH IndexClinical Endocrinology, 2009
- Expression of thyrotropin and thyroid hormone receptors in adipose tissue of patients with morbid obesity and/or type 2 diabetes: effects of weight lossInternational Journal of Obesity, 2009
- Serum Adipocyte Fatty Acid–Binding Protein as a New Biomarker Predicting the Development of Type 2 DiabetesDiabetes Care, 2007
- Thyroid Function Is Associated with Components of the Metabolic Syndrome in Euthyroid SubjectsJournal of Clinical Endocrinology & Metabolism, 2006
- Adipocyte Fatty Acid–Binding Protein Is a Plasma Biomarker Closely Associated with Obesity and Metabolic SyndromeClinical Chemistry, 2006
- Resistance to Thyroid Hormone Caused by Two Mutant Thyroid Hormone Receptors , R243Q and R243W, with Marked Impairment of Function That Cannot Be Explained by Altered in Vitro 3,5,3'-Triiodothyroinine Binding AffinityJournal of Clinical Endocrinology & Metabolism, 1997
- Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in manDiabetologia, 1985